You just read:

Argos Therapeutics To Present Progress Update On Adapt Phase 3 Trial With AGS-003 At 2014 Genitourinary Cancers Symposium

News provided by

Argos Therapeutics Inc.

Jan 28, 2014, 09:00 EST